810241C
TopFluor® TMR PE
Manufacturer: Sigma Aldrich
Synonym(S): 1-oleoyl-2-(6-((4,4-difluoro-1,3-dimethyl-5-(4-methoxyphenyl)-4-bora-3α,4α-diaza-s-indacene-2-propionyl)amino)hexanoyl)-sn-glycero-3- phosphoethanolamine
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 810241C-1-MG | In Stock | ₹ 45,887.40 |
810241C - 1 MG
In Stock
Quantity
1
Base Price: ₹ 45,887.40
GST (18%): ₹ 8,259.732
Total Price: ₹ 54,147.132
Assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 1 mL (810241C-1mg)
manufacturer/tradename
Avanti Polar Lipids 810241C
concentration
1 mg/mL (810241C-1mg)
shipped in
dry ice
storage temp.
−20°C
Related Products
Description
- General description: TopFluor® TMR PE is an acyl-chain-modified fluorescent phospholipid.[1] L-α-Phosphatidylethanolamine (PE) is a membrane phospholipid[2] and is the second most abundant phospholipid in animals, plants and yeast. It is the major lipid in bacteria.[3]
- Application: TopFluor® TMR PE is suitable to use as a component of vesicle and a donor-acceptor for fluorescence quenching.[4] It is also suitable for the formation of lipid membrane.[1]
- Biochem/physiol Actions: L-α-Phosphatidylethanolamine (PE) is essential for maintaining the structural integrity of membranes.[2] TopFluor® TMR PE is useful for cellular labelling.
- Packaging: 5 mL Amber Glass Screw Cap Vial (810241C-1mg)
- Legal Information: TopFluor is a registered trademark of Avanti Polar Lipids, Inc.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system
WGK
WGK 3
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810241C-1mg)
manufacturer/tradename: Avanti Polar Lipids 810241C
concentration: 1 mg/mL (810241C-1mg)
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 1 mL (810241C-1mg)
manufacturer/tradename:
Avanti Polar Lipids 810241C
concentration:
1 mg/mL (810241C-1mg)
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810252P-1mg)
manufacturer/tradename: Avanti Polar Lipids 810252P
concentration: __
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (810252P-1mg)
manufacturer/tradename:
Avanti Polar Lipids 810252P
concentration:
__
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (with stopper and crimp cap (810253P-1mg))
manufacturer/tradename: Avanti Polar Lipids 810253P
concentration: __
shipped in: dry ice
storage temp.: −70°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (with stopper and crimp cap (810253P-1mg))
manufacturer/tradename:
Avanti Polar Lipids 810253P
concentration:
__
shipped in:
dry ice
storage temp.:
−70°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810255P-1mg)pkg of 1 × 10 mg (810255P-10mg)pkg of 1 × 5 mg (810255P-5mg)
manufacturer/tradename: Avanti Polar Lipids
concentration: __
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (810255P-1mg)pkg of 1 × 10 mg (810255P-10mg)pkg of 1 × 5 mg (810255P-5mg)
manufacturer/tradename:
Avanti Polar Lipids
concentration:
__
shipped in:
dry ice
storage temp.:
−20°C